Working to Eradicate Gynecologic Cancers

Masoud Azodi, MD

Associate Professor
Yale University School of Medicine
Dept. of OB/GYN
333 Cedar Street
New Haven, CT
USA 06520

Papers:
140 Neratinib, an irreversible ErbB receptor tyrosine kinase inhibitor, shows efficacy in the treatment of HER2 amplified carcinosarcoma in vitro and in vivo 182 Cervical adenocarcinoma in situ: an institutional retrospective review of surgical management and outcome 262 Choice of adjuvant chemotherapy following neoadjuvant carboplatin/paclitaxel and delayed primary debulking 401 Mutations in the PIK3 pathway as a major determinant of trastuzumab resistance in uterine serous carcinoma